Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Lilly Announces Major China R&D Center

publication date: Nov 2, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Eli Lilly will build a bricks and mortar center dedicated to R&D work on diabetes in Shanghai. The center represents a major strategic departure for Lilly, which has touted its partnership approach with China’s innovative life science community. Lilly says diabetes in China, which has reached epidemic proportions, has a different molecular structure than diabetes elsewhere in the world. The company hopes to discover innovative solutions to the disease. More details...

Stock Symbol: (NYSE: LLY)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...